New research and findings from open-access journals and the U.S. research agencies.
In small trials, personalized treatment vaccines appeared to prevent cancer from returning in patients who had successful surgery to remove their tumors. The treatments, which were created based on intensive analyses of patients’ tumors, appeared to be safe.
Documented conversations on goals of care are uncommon in AYA patients with advanced cancer. Researchers found that many patients did not have these discussions until the last month of life, and many asked about palliative care.
Some cancers come back many years after successful treatment, often as metastatic disease. Researchers believe if and how this happens is heavily influenced by dormant cancer cells and their interaction with the immune system.
Plexin-B1 shapes glial networks around beta-amyloid plaques. An NIA-funded study has found that targeting it may improve plaque clearance and reduce brain inflammation.
A new drug targeting synaptic resilience shows potential in treating Alzheimer’s disease in an NIA-funded study, with early trials indicating safety and possible brain damage reduction. Further research is needed on the drug’s long-term effects.
How can diabetes health care professionals work with cardiologists to treat cardiovascular disease in people with diabetes? Learn more about managing heart disease and heart failure with lifestyle changes and medicines.
Researchers have developed a form of cancer treatment that uses fat cells engineered to aggressively consume nutrients like glucose. When implanted in mice, the engineered cells appeared to outcompete tumors for nutrients, shrinking tumors.
A modest cash-transfer intervention slowed memory decline and lowered dementia risk among midlife and older adults in rural South Africa.
An advance care planning intervention increased both the documentation of end-of-life preferences and potentially burdensome care.
NIA study reveals that nearly 42% of Americans over 55 may develop dementia, with new cases possibly doubling by 2060. Learn about the rising risk and future impact.
European adults with obesity who limited eating to any of three 8-hour window timeframes each day lost weight and improved cardiometabolic health.
How do obesity and type 2 diabetes affect heart and kidney health? Learn about how these conditions are connected, and how these links can affect your patients with type 2 diabetes.
A mother’s X chromosomes may turn off key genes, accelerate brain cell aging process, and impair learning and memory later in life.
An NIA-funded clinical trial investigating whether senolytics could improve bone health in older women had just subtle results.
NIA scientists developed an improved mouse model to study aging-related health decline, revealing how inflammation drives organ damage.
Bright spots in the brain called white matter hyperintensities contribute to Alzheimer’s risk. Reducing their accumulation might help slow or prevent the disease.
Missed mortgage and credit card payments may signal early cognitive decline years before a dementia diagnosis, according to an NIA-funded study.
Learn about fear of hypoglycemia in people with diabetes and what you can do to help.
Take a look back as we recap our most popular posts of 2024, plus three posts you may have missed.
Learn how you can help your patients with prediabetes or type 2 diabetes maintain weight loss over time.
Learn how health care professionals can help patients with diabetes make informed health decisions.
Learn about some of the unique challenges for older adults with diabetes and how health care professionals can help them manage their care.
Learn when to test for early stages of type 1 diabetes and how to delay it from progressing.
Along with lifestyle changes, weight-loss medications may help some people with type 2 diabetes and overweight or obesity manage their weight. Read on to learn more about when to consider weight-loss medications, which medications are preferred for people with type 2 diabetes, and how to incorporate them into diabetes care.